Trial NCT03519308

View at ClinicalTrials.gov 
Org. Study IDs: UPCC 22217

Last trial update was posted on 2024-03-15

MeSH Interventions

Gemcitabine Nivolumab Paclitaxel

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

The accrual goal could not be met and the drug manufacturer pulled support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID